Virtual Medicinal Product (VMP)
-
Cefalexin 250mg/5ml oral suspension
Name Details
Current Name
Cefalexin 250mg/5ml oral suspension
|
Start Date
SOT
|
End Date
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 5.0
- UDFS UOM
- ml
- Unit Dose UOM
- spoonful
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral suspension
- Ontology Form/Route
- suspension.oral
- Non-availability Indicator
- Actual Products Available
- Name Basis
- pINN - Proposed International Non-proprietary Name
Codes
- ATC Code
-
J01DB01
BNF |
Current BNF
05010201
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
05010201
|
Start Date
06-03-2009
|
End Date
03-04-2022
|
Previous BNF
05010200
|
Start Date
01-02-2005
|
End Date
05-03-2009
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
41943111000001105 |
09-06-2023 |
|
323888003 |
SOT |
08-06-2023 |
VMP Ingredients
VMP ingredients table
Cefalexin |
Based on Ingredient Substance |
|
50 mg |
1 ml |
Name
Cefalexin
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
50.0
Strength and UOM (Dmr)
1.0
Parent Products
-
VTM
Cefalexin
-
VMP
(Current) Cefalexin 250mg/5ml oral suspension
Virtual Medicinal Product Pack (VMPP) Information
100 ml |
564 |
Part VIIIA Category A |